首页> 外文期刊>Annals of Intensive Care >The effect of multidisciplinary extracorporeal membrane oxygenation team on clinical outcomes in patients with severe acute respiratory failure
【24h】

The effect of multidisciplinary extracorporeal membrane oxygenation team on clinical outcomes in patients with severe acute respiratory failure

机译:多学科体外膜氧合作用对重症急性呼吸衰竭患者临床结局的影响

获取原文
           

摘要

Abstract BackgroundThe Extracorporeal Life Support Organization (ELSO) has suggested that extracorporeal membrane oxygenation (ECMO) patients should be managed by a multidisciplinary team. However, there are limited data on the impact of ECMO team on the outcomes of patients with severe acute respiratory failure.MethodsAll consecutive patients with severe acute respiratory failure who underwent ECMO for respiratory support from January 2012 through December 2016 were divided into the pre-ECMO team period (before January 2014, n =?70) and the post-ECMO team period (after January 2014, n =?46). Clinical characteristics and outcomes were compared between the two groups.ResultsThe mortality rates in the intensive care unit (72.9 vs. 50.0%, P =?0.012) and hospital (75.7 vs. 52.2%, P =?0.009) were significantly decreased in the post-ECMO team period compared to the pre-ECMO team period. The median duration of ECMO support was not different between the two periods. However, the proportion of patients successfully weaned off ECMO was higher in the post-ECMO team period (42.9 vs. 65.2%, P =?0.018). During ECMO support, the incidence of cannula problems (32.9 vs. 15.2%, P =?0.034) and cardiovascular events (88.6 vs. 65.2%, P =?0.002) was reduced after implementation of the ECMO team. The 1-year mortality was significantly different between the pre-ECMO team and post-ECMO team periods (37.8 vs. 14.3%, P =?0.005).ConclusionAfter implementing a multidisciplinary ECMO team, survival rate in patients treated with ECMO for severe acute respiratory failure was significantly improved.
机译:抽象背景体外生命支持组织(ELSO)建议体外膜氧合作用(ECMO)患者应由多学科团队管理。然而,关于ECMO团队对严重急性呼吸衰竭患者结局的影响的数据有限。方法将2012年1月至2016年12月期间接受ECMO进行呼吸支持的所有连续严重急性呼吸衰竭患者分为ECMO前团队期间(2014年1月之前,n = 70)和ECMO后团队期间(2014年1月之后,n = 46)。比较两组的临床特征和结局。结果在重症监护病房,重症监护病房的死亡率(72.9 vs. 50.0%,P =?0.012)和医院的死亡率(75.7 vs. 52.2%,P =?0.009)显着降低。 ECMO之后的团队时期与ECMO之前的团队时期相比。 ECMO支持的中位持续时间在两个时期之间没有差异。然而,在ECMO小组会议后,成功从ECMO撤机的患者比例更高(42.9%对65.2%,P =?0.018)。在ECMO支持期间,实施ECMO团队后,插管问题的发生率(32.9%,对15.2%,P =?0.034)和心血管事件(88.6%对65.2%,P =?0.002)降低了。 ECMO之前和之后的1年死亡率有显着差异(37.8 vs. 14.3%,P =?0.005)。结论实施多学科ECMO团队后,接受ECMO治疗的重症急性期患者的生存率呼吸衰竭明显改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号